Document Type and Number:
Japanese Patent JPWO2021070883
Kind Code:
A1
Abstract:
The present invention provides an antibody that binds to an NTCP, capable of inhibiting infection of human hepatocytes with hepatitis B virus (HBV) particles. The present invention also provides an antibody that binds to an NTCP, capable of inhibiting infection of human hepatocytes with hepatitis B virus (HBV) particles, the antibody having a reduced effect on bile acid transport by NTCP.
Application Number:
JP2021551694A
Publication Date:
April 15, 2021
Filing Date:
October 07, 2020
Export Citation:
